Prevention of negative symptom psychopathologies in first-episode schizophrenia: Two-year effects of reducing the duration of untreated psychosis

Archives of General Psychiatry

Volumn 65, Issue 6, 2008, Pages 634-640

  Melle, Ingrid ^a,c   Larsen, Tor K ^d,e   Haahr, Ulrik ^f   Friis, Svein ^a,c   Johannesen, Jan O ^d   Opjordsmoen, Stein ^a,c   Rund, Bjørn R ^b,g   Simonsen, Erik ^f,h   Vaglum, Per ^b   McGlashan, Thomas ⁱ  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d STAVANGER UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

^f Psychiatric Research Unit   (Denmark)

^g VESTRE VIKEN HOSPITAL TRUST   (Norway)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; PSYCHOSIS; SCHIZOPHRENIA;

EID: 44649201545     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.65.6.634     Document Type: Article

References (31)

1. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62(9):975-983.
2. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005;162(10):1785-1804.
3. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry. 1999;46(7):899-907.
4. McGlashan TH. Early detection and intervention in schizophrenia: research. Schizophr Bull. 1996;22(2):327-345.
5. Johannessen JO, McGlashan TH, Larsen TK, Horneland M, Joa I, Mardal S, Kvebaek R, Friis S, Melle I, Opjordsmoen S, Simonsen E, Ulrik H, Vaglum P. Early detection strategies for untreated first-episode psychosis. Schizophr Res. 2001;51(1):39-46.
6. Larsen TK, Melle I, Friis S, Joa I, Johannessen JO, Opjordsmoen S, Simonsen E, Vaglum P, McGlashan TH. One-year effect of changing duration of untreated psychosis in a single catchment area. Br J Psychiatry. 2007;51(suppl):s128-s132.
7. Joa I, Johannessen JO, Auestad B, Friis S, McGlashan T, Melle I, Opjordsmoen S, Simonsen E, Vaglum P, Larsen TK. The key to reducing duration of untreated first psychosis: information campaigns [published online ahead of print September 28, 2007]. Schizophr Bull. doi:10.1093/schbul/sbm095.
8. Melle I, Haahr U, Friis S, Hustoft K, Johannessen JO, Larsen TK, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T. Reducing the duration of untreated first-episode psychosis - effects on baseline social functioning and quality of life. Acta Psychiatr Scand. 2005;112(6):469-473.
9. Melle I, Johannesen JO, Friis S, Haahr U, Joa I, Larsen TK, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T. Early detection of the first episode of schizophrenia and suicidal behavior. Am J Psychiatry. 2006;163(5):800-804.
10. Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry. 2004;61(2):143-150.
11. Larsen TK, Melle I, Auestad B, Friis S, Haahr U, Johannessen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T. Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull. 2006;32(4):758-764.
12. Carpenter WT Jr, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145(5):578-583.
13. Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32(2):214-219.
14. Buchanan RW. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull. 2007;33(4):1013-1022.
15. McGlashan TH. Is active psychosis neurotoxic? Schizophr Bull. 2006;32(4):609-613.
16. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
17. Goldner EM, Hsu L, Waraich P, Somers JM. Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can J Psychiatry. 2002;47(9):833-843.
18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structural Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID I/P, Version 2.0). New York: New York State Psychiatric Institute, Biometrics Research Department; 1995.
19. Bentsen H, Munkvold OG, Notland TH, Boye B, Bjoerge H, Lersbryggen AB, Oskarsson KH, Berg-Larsen R, Malt UF. The interrater reliability of the Positive and Negative Syndrome Scale (PANSS). Int J Methods Psychiatr Res. 1996;6:227-235.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Revised 3rd ed. Washington, DC: American Psychiatric Association; 1995.
21. Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the global assessment of functioning-split version. Compr Psychiatry. 2007;48(1):88-94.
22. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull. 1990;16(1):57-67.
23. Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann. 1988;11(1):51-62.
24. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470-484.
25. Larsen TK, Friis S, Haahr U, Johannessen JO, Melle I, Opjordsmoen S, Rund BR, Simonsen E, Vaglum PV, McGlashan TH. Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course. Br J Psychiatry. 2004;185:108-115.
26. Friis S, Larsen TK, Melle I, Opjordsmoen S, Johannessen JO, Haahr U, Simonsen E, Rund BR, Vaglum P, McGlashan T; Nordic Association for Psychiatric Epidemiology. Methodological pitfalls in early detection studies - the NAPE Lecture 2002. Acta Psychiatr Scand. 2003;107(1):3-9.
27. Muthén LK, Muthén BO. Mplus User's Guide. 4th ed. Los Angeles, CA: Muthén & Muthén; 2006.
28. Rogosa DR, Brandt D, Zimowski M. A growth curve approach to the measurement of change. Psychol Bull. 1982;92:726-748.
29. Larsen TK, McGlashan TH, Johannessen JO, Friis S, Guldberg C, Haahr U, Horneland M, Melle I, Moe LC, Opjordsmoen S, Simonsen E, Vaglum P. Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am J Psychiatry. 2001;158(11):1917-1919.
30. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr. The Schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989;30(2):119-123.
31. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001;58(2):165-171.